Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether regular screening (every 2 months) and treatment for bacterial vaginosis (BV \[infection of the vagina\]) will reduce the number of incidences of chla...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NCT07394777 · Bacterial Vaginosis (BV)
NCT01829204 · Vulvodynia, Mycoses, and more
NCT04046900 · Recurrent Bacterial Vaginosis
NCT04771728 · Bacterial Vaginosis
NCT06472765 · Bacterial Vaginosis, Candidiasis, and more
University of Alabama Hospital - Infectious Diseases
Birmingham, Alabama
San Francisco Department of Public Health - San Francisco City Clinic
San Francisco, California
RTI International - Women's Global Health Imperative
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions